Genoval Therapeutics

We are a startup company based in Shanghai China and Southern California USA. We are building a real-world evidence based, genomic data powered discovery and development platform to deliver next generation, data-driven RNA therapeutics as precision medicine. Our Strategy: Our strategy is to identify highly validated targets by mining databases containing human disease/allele specific mutations with associated clinical phenotype and treatment outcomes. Characterization of patient samples with different disease stages and treatments at molecular and cellular level enables accelerated drug development. We believe that informed decision-making from the best points of therapeutic intervention to clinical trial patient matching is critical to the success of drug development. We are building a multi-approach technology platform by integrating both current and next-generation RNA modifications, delivery technologies to improve targeted therapies for a range of diseases. Our goal is to deliver precision medicines to the right patients, the right disease stage, and the right diseased sites. Our people: We are a team of highly motivated, talented scientists consisting of both industry veterans and academic rising stars. Together we aim to make an impact to the rapidly growing field of RNA therapy and to expand the universe of medicines for the treatment of grievous diseases.